Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q2 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04).
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
